Veracyte Inc logo

Veracyte (VCYT) — Congressional Trading Activity

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Members Trading

3

All-time in Veracyte

Buyers vs Sellers

0Buyers/0Sellers

Members buying vs selling · last 90 days

Trades (90d)

0

Disclosed in the last 90 days

Avg Member Return

+77.6%

Top performers, TTM

Stock Report
$1K - $15K
StockPurchaseDemocratCaliforniaApr 07, 2026Mar 03, 2026House
$1K - $15K
StockPurchaseDemocratCaliforniaMar 09, 2026Feb 18, 2026House
$1K - $15K
StockSale (Partial)DemocratCaliforniaDec 15, 2025Nov 12, 2025House
$1K - $15K
StockPurchaseDemocratCaliforniaJul 10, 2025Jun 16, 2025House
$1K - $15K
StockPurchaseDemocratNew JerseyNov 11, 2023Oct 16, 2023House
$1K - $15K
StockSale (Partial)DemocratNew JerseyOct 15, 2023Sep 15, 2023House
$1K - $15K
StockSaleDemocratNew YorkMay 19, 2023Apr 10, 2023House
$1K - $15K
StockSale (Partial)CaliforniaJan 11, 2021Dec 10, 2020House
$1K - $15K
StockSale (Partial)CaliforniaJan 11, 2021Dec 23, 2020House
$1K - $15K
StockSale (Partial)DemocratNew JerseyJan 07, 2021Dec 08, 2020House
$1K - $15K
StockSale (Partial)CaliforniaNov 05, 2020Oct 29, 2020House
$1K - $15K
StockPurchaseCaliforniaFeb 18, 2020Jan 17, 2020House
$1K - $15K
StockPurchaseCaliforniaJan 10, 2020Dec 24, 2019House
$1K - $15K
StockPurchaseCaliforniaJan 10, 2020Dec 12, 2019House